Home/Filings/4/0001140361-17-046195
4//SEC Filing

Alecxih James 4

Accession 0001140361-17-046195

CIK 0001444380other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 1:20 PM ET

Size

7.4 KB

Accession

0001140361-17-046195

Insider Transaction Report

Form 4
Period: 2017-12-12
Alecxih James
Vice President, Sales
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-12-12+45,00045,000 total
    Exercise: $66.26Exp: 2027-12-11Common Stock (45,000 underlying)
  • Award

    Common Stock

    2017-12-12+12,00012,000 total
Footnotes (2)
  • [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on January 2 of each year, beginning January 2, 2019, subject to the Reporting Person's continued service to the issuer.
  • [F2]25% of the shares subject to the option vest on the first anniversary measured from December 12, 2017 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

NEVRO CORP

CIK 0001444380

Entity typeother

Related Parties

1
  • filerCIK 0001725232

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 1:20 PM ET
Size
7.4 KB